Development of an AI Assessment System for Pediatric Respiratory Distress : A Prospective Study
Condition(s) studied
Study summary
This is a multicenter, prospective observational study designed to collect clinical data for the development of a vision-language model-based artificial intelligence system for automated assessment of pediatric respiratory patterns.
The study enrolls pediatric patients aged 0 to 12 years who present to the pediatric emergency departments of participating institutions. Clinical and visual respiratory data are collected along with baseline clinical characteristics, including sex, age, body weight, height, presenting symptoms recorded at emergency department arrival, initial vital signs (body temperature, pulse rate, respiratory rate, blood pressure, and oxygen saturation), severity at presentation assessed by the Korean Triage and Acuity Scale (KTAS), emergency department management and outcomes such as hospital admission or discharge, and other relevant clinical information.
These data are used for cohort characterization and for the development and evaluation of an AI-based system that aims to automatically analyze pediatric respiratory patterns and support objective respiratory assessment in pediatric emergency care.
Eligibility
Primary outcome measure(s)
- Accuracy of automated respiratory pattern assessment — From study start through study completion (up to December 2027)
Performance of a vision-language model-based system in assessing pediatric respiratory patterns using clinical and visual respiratory data collected in pediatric emergency departments.
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| CHA Bundang Medical Center, CHA University, 9, Yatap-ro, Bundang-gu | Seongnam-si | Gyeonggi-do | Recruiting |
| Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu | Seoul | Seoul | Recruiting |
| Samsung Medical Center, 81, Irwon-ro, Gangnam-gu | Seoul | Seoul | Recruiting |
More Samsung Medical Center trials in South Korea
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07370623 on ClinicalTrials.gov ↗ ← All trials in South Korea